The use of iproniazid in the treatment of depressive states.
作者信息
HAWKINS J R, HILLARD W E, MOULTON J A, FABING H
出版信息
Ann N Y Acad Sci. 1959 Sep 17;80:745-53. doi: 10.1111/j.1749-6632.1959.tb49251.x.
Abstract
摘要
相似文献
1
The use of iproniazid in the treatment of depressive states.
Ann N Y Acad Sci. 1959 Sep 17;80:745-53. doi: 10.1111/j.1749-6632.1959.tb49251.x.
2
The inert psychasthenic reaction (anhedonia) as differentiated from classic depression and its response to iproniazid.
Ann N Y Acad Sci. 1959 Sep 17;80:669-79. doi: 10.1111/j.1749-6632.1959.tb49244.x.
3
Treatment of hospitalized mental patients with iproniazid.
Ann N Y Acad Sci. 1959 Sep 17;80:712-25. doi: 10.1111/j.1749-6632.1959.tb49248.x.
4
[The therapy of depressions].
J Med (Oporto). 1960 Feb 6;41:309-16.
5
Chemical treatment of depression.
Ann N Y Acad Sci. 1959 Sep 17;80:734-44. doi: 10.1111/j.1749-6632.1959.tb49250.x.
6
Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.
Ann N Y Acad Sci. 1959 Sep 17;80:652-68. doi: 10.1111/j.1749-6632.1959.tb49243.x.
7
[On monoamine-oxidase inhibitors].
Psychiatr Neurol (Basel). 1960 Jul;140:92-6.
8
[Our experiences with monoamine oxidase inhibiting substances].
Psychiatr Neurol (Basel). 1960 Jul;140:148-51.
9
A comparative trial of four monoamine oxidase inhibitors on chronic depressives.
J Ment Sci. 1961 May;107:538-46. doi: 10.1192/bjp.107.448.538.
10
The place of iproniazid in biochemical psychiatry.
Ann N Y Acad Sci. 1959 Sep 17;80:797-808. doi: 10.1111/j.1749-6632.1959.tb49256.x.
Zotero 插件